Market Closed -
Bombay S.E.
11:00:54 04/07/2024 BST
|
5-day change
|
1st Jan Change
|
11,642
INR
|
+0.47%
|
|
-1.73%
|
+28.94%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
18,408
|
17,499
|
21,922
|
40,004
|
50,673
|
37,717
|
Enterprise Value (EV)
1 |
19,679
|
19,914
|
22,405
|
39,263
|
52,406
|
37,511
|
P/E ratio
|
18.7
x
|
15.7
x
|
13.9
x
|
24.4
x
|
28.8
x
|
30.3
x
|
Yield
|
0.03%
|
0.04%
|
0.03%
|
0.02%
|
0.01%
|
0.02%
|
Capitalization / Revenue
|
2.31
x
|
1.76
x
|
1.8
x
|
3.66
x
|
3.89
x
|
3.06
x
|
EV / Revenue
|
2.47
x
|
2.01
x
|
1.84
x
|
3.6
x
|
4.03
x
|
3.04
x
|
EV / EBITDA
|
12.4
x
|
10.6
x
|
9.76
x
|
16.3
x
|
20.4
x
|
19
x
|
EV / FCF
|
-58
x
|
-15.9
x
|
13.6
x
|
34.7
x
|
-35.3
x
|
21.9
x
|
FCF Yield
|
-1.72%
|
-6.31%
|
7.33%
|
2.88%
|
-2.83%
|
4.56%
|
Price to Book
|
6.17
x
|
4.28
x
|
3.89
x
|
5.5
x
|
6.58
x
|
4.22
x
|
Nbr of stocks (in thousands)
|
4,249
|
4,249
|
4,249
|
4,249
|
4,155
|
4,155
|
Reference price
2 |
4,333
|
4,119
|
5,160
|
9,416
|
12,195
|
9,077
|
Announcement Date
|
25/09/18
|
31/08/19
|
03/09/20
|
11/08/21
|
09/08/22
|
30/05/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,953
|
9,922
|
12,151
|
10,920
|
13,012
|
12,343
|
EBITDA
1 |
1,582
|
1,875
|
2,296
|
2,409
|
2,571
|
1,973
|
EBIT
1 |
1,418
|
1,704
|
2,077
|
2,153
|
2,322
|
1,714
|
Operating Margin
|
17.83%
|
17.18%
|
17.09%
|
19.71%
|
17.85%
|
13.88%
|
Earnings before Tax (EBT)
1 |
1,356
|
1,551
|
2,052
|
2,154
|
2,337
|
1,740
|
Net income
1 |
983.1
|
1,115
|
1,576
|
1,639
|
1,760
|
1,246
|
Net margin
|
12.36%
|
11.24%
|
12.97%
|
15.01%
|
13.53%
|
10.1%
|
EPS
2 |
231.4
|
262.5
|
371.0
|
385.7
|
423.5
|
299.9
|
Free Cash Flow
1 |
-339.3
|
-1,256
|
1,641
|
1,130
|
-1,485
|
1,709
|
FCF margin
|
-4.27%
|
-12.66%
|
13.51%
|
10.35%
|
-11.42%
|
13.85%
|
FCF Conversion (EBITDA)
|
-
|
-
|
71.5%
|
46.91%
|
-
|
86.62%
|
FCF Conversion (Net income)
|
-
|
-
|
104.12%
|
68.97%
|
-
|
137.16%
|
Dividend per Share
2 |
1.500
|
1.500
|
1.500
|
1.500
|
1.500
|
1.500
|
Announcement Date
|
25/09/18
|
31/08/19
|
03/09/20
|
11/08/21
|
09/08/22
|
30/05/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,271
|
2,415
|
483
|
-
|
1,733
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
741
|
-
|
207
|
Leverage (Debt/EBITDA)
|
0.8034
x
|
1.288
x
|
0.2104
x
|
-
|
0.6741
x
|
-
|
Free Cash Flow
1 |
-339
|
-1,256
|
1,641
|
1,130
|
-1,485
|
1,709
|
ROE (net income / shareholders' equity)
|
39.4%
|
31.5%
|
32.4%
|
25.4%
|
23.5%
|
15%
|
ROA (Net income/ Total Assets)
|
20.3%
|
16.9%
|
17.2%
|
16.2%
|
14.5%
|
9.92%
|
Assets
1 |
4,844
|
6,593
|
9,154
|
10,109
|
12,112
|
12,560
|
Book Value Per Share
2 |
702.0
|
962.0
|
1,328
|
1,712
|
1,853
|
2,150
|
Cash Flow per Share
2 |
2.900
|
13.00
|
107.0
|
62.70
|
0.8100
|
44.70
|
Capex
1 |
410
|
478
|
584
|
304
|
557
|
235
|
Capex / Sales
|
5.15%
|
4.82%
|
4.81%
|
2.79%
|
4.28%
|
1.91%
|
Announcement Date
|
25/09/18
|
31/08/19
|
03/09/20
|
11/08/21
|
09/08/22
|
30/05/23
|
|
1st Jan change
|
Capi.
|
---|
| -12.93% | 3.1B | | -40.86% | 1.63B | | -18.55% | 1.5B | | -16.45% | 1.44B | | -35.30% | 1.43B | | -11.88% | 1.17B | | -11.99% | 1.01B | | +60.81% | 897M | | -34.75% | 883M |
Pesticide
|